It also stimulated the synthesis of Th1 cytokines and anti-tumor immunity via T-cell receptor activation in CD8+ and Vγ9Vδ2+ T-cells, as validated by CRISPR/Cas9 VDR knockout and overexpression, respectively. The gene discussed is CD8A; the disease is neoplasm.